CN1278558A - Asynchronous chain-extending polymerase chain reaction - Google Patents

Asynchronous chain-extending polymerase chain reaction Download PDF

Info

Publication number
CN1278558A
CN1278558A CN 99114949 CN99114949A CN1278558A CN 1278558 A CN1278558 A CN 1278558A CN 99114949 CN99114949 CN 99114949 CN 99114949 A CN99114949 A CN 99114949A CN 1278558 A CN1278558 A CN 1278558A
Authority
CN
China
Prior art keywords
necrosis factor
tumor
factor glycoproteins
dna
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 99114949
Other languages
Chinese (zh)
Inventor
夏庆杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 99114949 priority Critical patent/CN1278558A/en
Publication of CN1278558A publication Critical patent/CN1278558A/en
Pending legal-status Critical Current

Links

Abstract

The present invention relates to a kind of two chains asynchronously-elongated DNA amplification technology in vitro, which is characterized by that firstly, a pair of specific primers is synthesized according to target DNA sequence to be amplified, then a repetitive sequence complementary oligo-repetitive sequence of 3'target DNA chain whose tail end is modified and elongation vitality is lost, then said oligo-repetitive sequence, chain primer, heat-resisting DNA polymerase, dNTP substrate, template DNA, magnesium ion, PCR buffer solution and ultra-pure water are mixed uniformly and made into reaction system, then said reaction system is undergone the processes of high-temp., low-temp., medium-low temp., medium-temp, and repeated heat circulation treatment in the heat-circulating instrument to obtain million copies of specific target DNA fragments. Said invention adopts multiple repeated heat circulation process, so that is can product lots of target DNA fragments.

Description

Asynchronous chain-extending polymerase chain reaction
The present invention relates to a kind of positive and negative two the asynchronous synthetic DNA of chain amplification in vitro technology.
In existing DNA amplification in vitro technology, polymerase chain reaction (polymeras chain reaction, PCR) be main also be otherwise effective technique.The reaction system that hot resistant DNA polymerase, Auele Specific Primer, dNTP substrate, template DNA, magnesium ion etc. will be contained in this technology system carries out repeatedly that the sex change of high temperature template, low temperature primer combine with template, the thermal cycling of middle temperature primer extension, and target dna fragment is increased external obtaining.But when the tumor-necrosis factor glycoproteins of the big copy number of amplification, because the tumor-necrosis factor glycoproteins template is easy to anneal, conventional PCR is difficult to obtain satisfied amplification.At first be that amplification efficiency is low, general detection means such as ethidium bromide staining or silver dye and are difficult to detect, and secondly are to occur many shadow bands easily, influence the judgement of amplification.We think that this mainly is because tumor-necrosis factor glycoproteins is easy to mutual annealing when low temperature and middle temperature, have influenced that the building-up process of new chain and combined coefficient cause.Have not yet to see the way that fundamentally solves this difficult problem.
It is a kind of simple to operate that the object of the invention is to provide, the DNA amplification in vitro technology of the tumor-necrosis factor glycoproteins of the big copy number that can effectively increase.
Asynchronous chain-extending polymerase chain reaction of the present invention (asynchronous strand-extension polymerase chain reaction, ASE-PCR) at first according to the synthetic a pair of specific strand primer of target DNA sequence to be amplified, this a pair of primer defines the target dna fragment that will increase, the tumor-necrosis factor glycoproteins that synthesizes one section 15-20 base again according to the tumor-necrosis factor glycoproteins that will increase, and add dideoxy nucleotide or phosphorylation modification at its 3 '-end, make it lose the extension ability, the note do few tumor-necrosis factor glycoproteins (oligo-repeat sequence, ORS).ORS, primer, hot resistant DNA polymerase, dNTP substrate, template DNA, magnesium ion, PCR damping fluid, ultrapure water etc. are mixed into reaction system, on thermal cycler, carry out the thermal cycling repeatedly of high temperature, low temperature, middle low temperature, middle temperature.When reaction system is in high temperature, the template DNA sex change; When system dropped to low temperature and middle low temperature, primer combined the synthetic of the new chain of guiding with special target DNA, simultaneously, the annealing of the tumor-necrosis factor glycoproteins of ORS and its complementary strand, thus the tumor-necrosis factor glycoproteins between the inhibition template is annealed mutually.In can at first not instruct the synthetic new chain of complete complementation as template during low temperature with ORS bonded chain; Then be obstructed with ORS bonded chain, can not synthesize the new chain of complete complementation at the new chain extension in tumor-necrosis factor glycoproteins district.In when temperature ORS from separating with its bonded template strand, this template then can instruct the synthetic new chain of complete complementation this moment.Through after 25-35 the thermal cycling, just can obtain the special target dna fragment that contains tumor-necrosis factor glycoproteins of copies up to a million like this.
(fragile X mental retardation 1,5 ' non-translational region FMR1) is that example is elaborated with No. 1 gene of amplification fragile X mental retardation below.
At first according to sequence (GenBanK S74494 and the Nature Genet of FMR1,8 (1) 88-94,1994) synthetic special positive primers F the F:5 '-GTTTCGGTTTCACCTTCCGGTGGAGG-3 ' of a pair of FMR1, FR:5 ' CCTCCATCTTCTCTTCAGCCCTGC-3 '; The few tumor-necrosis factor glycoproteins of resynthesis also carries out phosphorylation or add dideoxy nucleotide modifying at its 3 '-end: 5 '-CGGCGGCGGCGGCGGCGG-3 ', note is made ORS
Mix the 50ul reaction system, include each 20pmol of two primers, few tumor-necrosis factor glycoproteins ORS100pmol normal people DNA 50-100 ng, the 1XPCR damping fluid, Taq archaeal dna polymerase 2u, Mg++Final concentration 2mmol/L, 96 ℃ of following sex change 5 minutes, then on PE9600 by 96 ℃ 20 seconds, 56 ℃ 30 seconds, 65 ℃ 30 seconds, 75 ℃ of down circulations 35 times in 1 minute 30 seconds, 2% agarose gel electrophoresis, ethidium bromide staining, ultraviolet lamp are observed down, can find to expect the DNA band of size.
In the above-mentioned reaction system, when reaction system is in high temperature, the template DNA sex change; When system drops to 56 ℃ and 65 ℃, primer combines the synthetic of the new chain of guiding with special target DNA, simultaneously, ORS and (GCC) n tumor-necrosis factor glycoproteins annealing, thereby the tumor-necrosis factor glycoproteins between the inhibition template is annealed mutually, does not make and can at first instruct synthetic complete complementary new chain as template with ORS bonded (CGG) n chain; Then be obstructed with ORS bonded chain, can not synthesize the new chain of complete complementation at the new chain extension in tumor-necrosis factor glycoproteins district.ORS separates from (GCC) n template strand in the time of 75 ℃, makes this template can instruct the synthetic new chain of complete complementation this moment.Through after 25-35 the thermal cycling, just can obtain the special target dna fragment that contains tumor-necrosis factor glycoproteins of copies up to a million like this.

Claims (5)

1, a kind of reaction system that will contain few tumor-necrosis factor glycoproteins, primer, hot resistant DNA polymerase, dNTP substrate, template DNA, magnesium ion, PCR damping fluid, ultrapure water etc. is carried out high temperature, low temperature, middle low temperature, middle temperature thermal cycling and the DNA amplification in vitro technology of a large amount of amplifications of the dna fragmentation that achieves the goal repeatedly, few tumor-necrosis factor glycoproteins wherein is a bit of tumor-necrosis factor glycoproteins complementary oligonucleotide according to the tumor-necrosis factor glycoproteins synthetic of target DNA and one bar chain, and its 3 '-terminal process is modified the extension ability that lost; The low temperature of this widow's tumor-necrosis factor glycoproteins in the thermal cycling process and in during low thermophase, with the tumor-necrosis factor glycoproteins annealing of corresponding complementary template strand, thus the tumor-necrosis factor glycoproteins that suppresses between the template anneal mutually, make another template strand at first instruct synthetic complete complementary new chain; During middle thermophase in the thermal cycling process, from separating with its bonded template strand, this template instructs the synthetic new chain of complete complementation immediately; Through thermal cycling repeatedly, produce a large amount of target DNA fragments.
2, DNA amplification in vitro technology according to claim 1 is characterized in that containing in the reaction system few tumor-necrosis factor glycoproteins.
3, few tumor-necrosis factor glycoproteins according to claim 2, to it is characterized by be tumor-necrosis factor glycoproteins synthetic 3 ' according to target DNA-end loses the oligonucleotide extension ability and a tumor-necrosis factor glycoproteins complementary 15-25nt chain through modifying.
4, the 3 '-terminal oligonucleotide that loses the extension ability according to claim 3 through modifying, its 3 '-end carries out phosphorylation or adds dideoxy nucleotide modifying, or use other materials that can combine with positive primer specific but can not under the effect of hot resistant DNA polymerase, extend, as peptide nucleic acid(PNA) (PNA).
5, DNA amplification in vitro technology according to claim 1 is according to the DNA amplification in vitro test kit of this technology assembling.
CN 99114949 1999-06-22 1999-06-22 Asynchronous chain-extending polymerase chain reaction Pending CN1278558A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 99114949 CN1278558A (en) 1999-06-22 1999-06-22 Asynchronous chain-extending polymerase chain reaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 99114949 CN1278558A (en) 1999-06-22 1999-06-22 Asynchronous chain-extending polymerase chain reaction

Publications (1)

Publication Number Publication Date
CN1278558A true CN1278558A (en) 2001-01-03

Family

ID=5277978

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 99114949 Pending CN1278558A (en) 1999-06-22 1999-06-22 Asynchronous chain-extending polymerase chain reaction

Country Status (1)

Country Link
CN (1) CN1278558A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102146447A (en) * 2011-01-12 2011-08-10 山东博奥克生物科技有限公司 Nest coamplific action polymerase chain reaction kit
CN102251027A (en) * 2011-06-07 2011-11-23 刘钦松 Suppression polymerase chain reaction kit
CN110358796A (en) * 2019-07-06 2019-10-22 天津大学 A kind of inexpensive DNA synthetic method of the archaeal dna polymerase based on template dependant
CN110527713A (en) * 2019-07-02 2019-12-03 黄天谊 A kind of PCR amplification method folding primer
WO2021114135A1 (en) * 2019-12-11 2021-06-17 清华大学 Blocking-type chain polymerization amplification reaction based in vitro fast synthesis of medium and high-copy dna repetitive sequence

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102146447A (en) * 2011-01-12 2011-08-10 山东博奥克生物科技有限公司 Nest coamplific action polymerase chain reaction kit
CN102146447B (en) * 2011-01-12 2013-06-26 山东博奥克生物科技有限公司 Nest coamplific action polymerase chain reaction kit
CN102251027A (en) * 2011-06-07 2011-11-23 刘钦松 Suppression polymerase chain reaction kit
CN102251027B (en) * 2011-06-07 2013-06-26 刘钦松 Suppression polymerase chain reaction kit
CN110527713A (en) * 2019-07-02 2019-12-03 黄天谊 A kind of PCR amplification method folding primer
CN110527713B (en) * 2019-07-02 2024-01-30 黄天谊 PCR amplification method of folding primer
CN110358796A (en) * 2019-07-06 2019-10-22 天津大学 A kind of inexpensive DNA synthetic method of the archaeal dna polymerase based on template dependant
WO2021114135A1 (en) * 2019-12-11 2021-06-17 清华大学 Blocking-type chain polymerization amplification reaction based in vitro fast synthesis of medium and high-copy dna repetitive sequence

Similar Documents

Publication Publication Date Title
US5114839A (en) Process for dna sequencing using oligonucleotide bank
US20110059868A1 (en) Process for amplifying nucleic acids
US7662594B2 (en) Helicase-dependent amplification of RNA
EP2614154B1 (en) Method for reducing adapter-dimer formation
Zyrina et al. N. BspD6I DNA nickase strongly stimulates template-independent synthesis of non-palindromic repetitive DNA by Bst DNA polymerase
EP3029146B1 (en) Reduced inhibition of one-step rt-pcr
JP5200302B2 (en) Identification of RNA targets using helicases
CA2358992A1 (en) Method for controlling the extension of an oligonucleotide
US20200048693A1 (en) Method for nucleic acid amplification
KR100559098B1 (en) Method for synthesizing dna
WO1999049081A3 (en) Amplification of nucleic acids
Naito et al. Ribosomal ribonucleic acid (rRNA) gene typing for species identification
EP2151506A1 (en) Method of amplifying target nucleic acid sequence by multiple displacement amplification including thermal cycling
EP3498861A1 (en) Rna reverse transcription amplification method
CN1278558A (en) Asynchronous chain-extending polymerase chain reaction
Diggelmann et al. Enzymatic synthesis of DNA complementary to purified 14S messenger RNA of immunoglobulin light chain
Liu et al. Single-step direct PCR amplification from solid tissues
Laulier et al. An easy method for preserving nucleic acids in field samples for later molecular and genetic studies without refrigerating
CN114341150A (en) Compositions and methods for enhancing reverse transcriptase activity and/or reducing reverse transcriptase inhibition
CN1238387A (en) Double-chain primer polymerase chain reaction
Prep Inverse PCR & cycle sequencing of P element insertions for STS generation
Francisco-Candeira et al. Development of microsatellite markers in the razor clam Solen marginatus (Bivalvia: Solenidae)
US6838266B2 (en) Method for producing DNA
WO2023137407A1 (en) Methods and compositions for fast nucleic acid amplifications
Zheleznaya et al. PCR fragmentation of DNA

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication